Blog Series

Series: An Exploration of Addiction

by Pablo Bolanos on March 21, 2017

The term “recreational” defines as an activity done for enjoyment when one is not working. Skiing, knitting, sporting leagues, and book clubs are examples of recreational activities that can enhance our overall life experience. Recreational is also a word used to describe the casual use of mind-altering substances such as drugs and alcohol. Because these behaviors are often exhibited in social settings, recreational drug and alcohol use is oftentimes perceived as harmless, non habit-forming behavior due to its informal nature and seemingly broad social acceptance.

However, a thin line separates the casual use of drugs and alcohol and the potential steep fall into a serious substance abuse disorder. Substance abuse disorders manifest when the recurrent use of drugs and/or alcohol causes clinically and functionally significant impairment, such as health problems, disability, and failure to meet major responsibilities at work, school, or home according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Why then, are some people able to casually enjoy a cocktail on the weekend while firing up the grill, while others end up crossing the line from recreational use to addiction? And, when a user’s life is flipped upside down because of their physical and psychological dependence on mind-altering substances, what are they and their loved ones to do?

In this new series, we will take a deeper dive into what decades of psychological and pharmacological research have to tell us about the science behind substance abuse disorders and addiction, how individuals are affected, and what employers can do to both thwart problematic behavior and to offer aid through established Employee Assistance Programs (EAP).

To learn more about drugs of abuse, visit our resources page or our common drugs of abuse literature.

By the Numbers: Going Green with eCCF

by Steve Beller on March 1, 2017

Our By the Numbers blog series takes a closer look at the numbers, facts, data, and outputs that impact workplace drug testing programs. In this post, we examine the environmental impact of moving from paper-based custody and control forms (CCF) to electronic custody and control forms (eCCF).

Paper-based CCFs have been a mainstay of the drug testing industry since its inception in the 1980s, when the Reagan Administration passed the Drug-Free Workplace Act of 1988. According to the Society for Human Resource Management (SHRM), “the Drug-Free Workplace Act of 1988 requires some federal contractors and all federal grantees to agree that they will provide drug-free workplaces as a condition of receiving a contract or grant from a federal agency.” In 2016, Quest Diagnostics processed more than 11 million workplace drug tests. Moreover, on average, we supply our employer clients with 1.5 paper forms for each drug test conducted. And while a single 5-part paper form may not seem like much, 16.5 million such forms add up—and the environmental impact is dramatic. If eCCFs were used for every Quest Diagnostics drug test performed instead of paper CCFs, 10,000 trees could have been saved in 2016 alone. Expanding the calculation to the entire drug testing industry, an estimated 42,000+ trees could potentially be saved each year.

Quest Diagnostics has been investing in and providing eCCF (formerly known as eReq) to non-regulated employers for nearly a decade, and we launched eCCF for regulated, U.S. Department of Transportation (DOT) drug tests this January. eCCF is currently available for DOT urine, non-DOT urine, Express Results™ Online, oral fluid, and hair drug tests from Quest Diagnostics.

For more information on drug testing, visit our website or contact us online.

Weeding Out the Facts Webinar Recap

February 21, 2017 Webinars

Employers face challenges as states continue to pass marijuana legislation, while the substance is still illegal under federal law.  In our recent webinar, two highly-regarded industry experts, Dr. Barry Sample, Senior Director of Science and Technology, Quest Diagnostics, and D. Faye Caldwell, Attorney at Law, Caldwell Everson, presented facts and insight about marijuana and the workplace […]

Read the full article →

Data Shows Escalating Drug Use in the U.S. Workforce

January 24, 2017 Drug Testing

The Quest Diagnostics Drug Testing Index™ (DTI) is arguably the industry’s longest standing, most frequently relied upon resource for drug trends in the American workforce by policymakers, media, employers, and the general public. The DTI examines positivity by drug category, testing reason, and specimen type. Since its inception in 1988, this report has analyzed millions […]

Read the full article →

Webinar: Marijuana & the Workplace

January 9, 2017 Webinars

Voters passed new measures this election season to allow recreational and medicinal marijuana use in their states, bringing the count to 29 states where cannabis is “legal” in some form. Research also indicates relaxing attitudes towards marijuana and a 2015 Gallup Poll showed that 1 in 4 people have tried the drug. The Quest Diagnostics Drug Testing […]

Read the full article →

Post-Accident Positivity Climbs Among American Workers

January 4, 2017 Drug Testing

Our scientific experts have analyzed and published annual workplace drug testing data and insights since 1988 in the Quest Diagnostics Drug Testing Index™ (DTI). After the initiation of drug testing programs by employers in the 1980s, overall positivity rates began to decline. Employers saw how the power of drug-free workplace programs deterred employee substance abuse […]

Read the full article →

Ask the Experts: Getting Started with eCCF

December 21, 2016 Webinars

Our recent Gain the eCCF Advantage webinar was well received by many in the drug testing industry. Throughout the presentation, our audience posed a number of questions. Answers to the most frequent and important inquiries from the webinar are provided below as part of our ongoing effort to simplify the complexities of electronic Custody and […]

Read the full article →

By the Numbers: Heroin Positivity Continues to Rise

December 15, 2016 By the Numbers

Our By the Numbers blog series takes a closer look at the numbers, facts, data, and outputs that impact workplace drug testing programs. In this post, we look at the heroin positivity rate. Headlines continue to put a spotlight on startling statistics about heroin addiction and sometimes feature shocking stories to warn the public of the drug’s dangers. The […]

Read the full article →

Navigating Global Drug Testing Webinar Highlights

December 14, 2016 Webinars

Data privacy, drug screen turnaround time, collection network coverage, and logistics form the pillars of an effective international drug testing program. A “one size fits all” approach cannot be taken because factors such as culture, customs, currency, policies, and laws can vary greatly from country to country. In our most recent webinar, our experts offered […]

Read the full article →

By the Numbers: Drug Detection Window by Specimen Type

December 5, 2016 By the Numbers

Our ongoing By the Numbers series takes a closer look at the numbers, facts, and data that impact workplace drug testing programs. This week, we examine one of the most frequently asked questions we receive as a laboratory: how long can drugs be detected using a drug test? The answer is not simple as you might think, […]

Read the full article →